Medicure (CVE:MPH) Stock Price Crosses Below 50-Day Moving Average – Time to Sell?

Medicure Inc. (CVE:MPH)’s stock price crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of C$1.21 and traded as low as C$1.16. Medicure shares last traded at C$1.16, with a volume of 200 shares.

Medicure Stock Down 5.7%

The firm has a 50-day moving average price of C$1.21 and a two-hundred day moving average price of C$1.16. The firm has a market cap of C$12.11 million, a price-to-earnings ratio of -3.52 and a beta of 0.91. The company has a debt-to-equity ratio of 4.65, a quick ratio of 1.29 and a current ratio of 2.03.

Medicure Company Profile

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications.